VELETRI 0,5 mg, poudre et solvant pour solution pour perfusion

( ARTG ) VELETRI is indicated for the long-term treatment, via continuous intravenous infusion, in WHO functional class III or class IV patients with:, Idiopathic pulmonary arterial hypertension, Familial pulmonary arterial hypertension, Pulmonary arterial hypertension associated with the scleroderma spectrum of diseases